CD274 and neoplasm: In addition to their failure as monotherapy treatments, the combination of immunotherapy and TKIs did not result in a synergistic anti-tumour effect, neither in cell lines carrying EGFR mutations and PD-L1 upregulation [16] nor in patients [24,25,26,27].